Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares

NEXT STORY
Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
PREV STORY
India Medical Plastics Market Size, Share & Trends Analysis Report By Product, By Application And Segment Forecasts, 2020 – 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innovation Pharmaceuticals Provides Update on Kevetrin Program; Bridging Toxicology Efforts Aimed at Developing an Oral p53 Anti-Cancer Drug Candidate

BEVERLY, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...

author_avatar
NASDAQ Market News

Cognoa Hits Major Milestone Towards First AI-Based Autism Diagnostic

PALO ALTO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Cognoa, a company offering an ...

author_avatar
NASDAQ Market News

Profound Medical Announces Second Quarter 2018 Financial Results

TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or ...

author_avatar
NASDAQ Market News